Literature DB >> 11735359

Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304.

Y Deng1, H Xu, K Huang, X Yang, C Xie, J Wu.   

Abstract

Regulation of endothelial cell apoptosis is a critical modulator of normal and pathological angiogenesis. Inorganic arsenic, especially arsenic trioxide, has been demonstrated to induce clinical remission in patients with acute promyelocytic leukemia as well as those with several solid cancers. So, in this study, we examined the in vitro effect of realgar(As2S2), used to treat human diseases for centuries in traditional Chinese medicine, on cell survival and apoptosis in a human umbilical vein endothelial cell (HUVEC) line: ECV-304. Four different suspensions of realgar particles with diameters from 100-500 nm containing equivalent doses were investigated to determine their size effects. After 2, 4, 6 and 8 h, realgar particles of diameters 100 nm and 150 nm obviously reduced ECV-304 cell survival, which was evidenced by a reduction of cell viability in the MTT assay, whereas cells exhibited slight viability reduction in response to treatment with realgar particles of diameters 200 nm and 500 nm. Significant apoptosis was identified by morphological observation, flow cytometry assay and DNA gel electrophoresis in the ECV-304 cells by the presence of realgar particles of diameters 100 nm and 150 nm. It is demonstrated that particles of realgar with average diameters from 100 nm to 150 nm can induce ECV-304 cell apoptosis. These results suggest that particles of realgar smaller than 150 nm may provide a less toxic agent for anti-neoplasia by suppressing angiogenesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735359     DOI: 10.1006/phrs.2001.0885

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study.

Authors:  Mari Maeda-Yamamoto; Kaori Ema; Yoshiko Tokuda; Manami Monobe; Hirofumi Tachibana; Yoichi Sameshima; Shinichi Kuriyama
Journal:  Cytotechnology       Date:  2011-01-05       Impact factor: 2.058

2.  Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.

Authors:  Qi-Hong Zhao; Ying Zhang; Yun Liu; Hui-Li Wang; Yuan-Yuan Shen; Wen-Jun Yang; Long-Ping Wen
Journal:  Med Oncol       Date:  2009-03-12       Impact factor: 3.064

3.  Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.

Authors:  Yan-Feng Xiao; De-Dong Wu; Shan-Xi Liu; Xi Chen; Li-Fen Ren
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

4.  Leptospira interrogans induces apoptosis in macrophages via caspase-8- and caspase-3-dependent pathways.

Authors:  Dandan Jin; David M Ojcius; Dexter Sun; Haiyan Dong; Yihui Luo; Yafei Mao; Jie Yan
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

Review 5.  Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).

Authors:  Peter Baláž; Ján Sedlák
Journal:  Toxins (Basel)       Date:  2010-06-21       Impact factor: 4.546

6.  Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines.

Authors:  Weizhong Zhao; Xun Lu; Yuan Yuan; Changsheng Liu; Baican Yang; Hua Hong; Guoying Wang; Fanyan Zeng
Journal:  Int J Nanomedicine       Date:  2011-08-02

Review 7.  Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent.

Authors:  Peng Chen; Ruixiang Xu; Lei Yan; Zhengrong Wu; Yan Wei; Wenbin Zhao; Xin Wang; Qinjian Xie; Hongyu Li
Journal:  Biol Res       Date:  2017-05-22       Impact factor: 5.612

8.  Enhanced antitumor activity of realgar mediated by milling it to nanosize.

Authors:  Ye Tian; Xiaobo Wang; Ronggang Xi; Weisan Pan; Shuang Jiang; Zhao Li; Yu Zhao; Guanghui Gao; Dan Liu
Journal:  Int J Nanomedicine       Date:  2014-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.